Anil Kamat is a recognized clinical leader in hematology, with extensive experience in both clinical and manufacturing contexts. He is head of clinical development at Immuneel Therapeutics, based in Bengaluru, India, and serves as a consultant hematologist for the UK National Health Service. Dr Kamat is a member and contributor to several societies, including the International Society for Cell and Gene Therapy, the American Society of Hematology, and the European Group for Blood and Marrow Transplantation.
